Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.

OBJECTIVE:Data concerning the effect of current smoking on solely new-generation drug-eluting stents (DES) are limited. We investigated the impact of current smoking on 2-year clinical outcomes between durable-polymer (DP)-coated DES (zotarolimus-eluting [ZES] and everolimus eluting [EES]) and biode...

Full description

Bibliographic Details
Main Authors: Yong Hoon Kim, Ae-Young Her, Myung Ho Jeong, Byeong-Keuk Kim, Sung-Jin Hong, Dong-Ho Shin, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6173404?pdf=render
_version_ 1818368975068725248
author Yong Hoon Kim
Ae-Young Her
Myung Ho Jeong
Byeong-Keuk Kim
Sung-Jin Hong
Dong-Ho Shin
Jung-Sun Kim
Young-Guk Ko
Donghoon Choi
Myeong-Ki Hong
Yangsoo Jang
author_facet Yong Hoon Kim
Ae-Young Her
Myung Ho Jeong
Byeong-Keuk Kim
Sung-Jin Hong
Dong-Ho Shin
Jung-Sun Kim
Young-Guk Ko
Donghoon Choi
Myeong-Ki Hong
Yangsoo Jang
author_sort Yong Hoon Kim
collection DOAJ
description OBJECTIVE:Data concerning the effect of current smoking on solely new-generation drug-eluting stents (DES) are limited. We investigated the impact of current smoking on 2-year clinical outcomes between durable-polymer (DP)-coated DES (zotarolimus-eluting [ZES] and everolimus eluting [EES]) and biodegradable-polymer (BP)-coated biolimus-eluting stent (BES) in acute myocardial infarction (AMI) patients after successful percutaneous coronary intervention (PCI). METHODS:Finally, a total of 8357 AMI patients with current smoking underwent successful PCI with new-generation DES (ZES, EES, and BES) were enrolled and divided into three groups as ZES (n = 3199), EES (n = 3987), and BES group (n = 1171). The primary endpoint was the occurrence of major adverse cardiac events (MACE) defined as all-cause death (cardiac death [CD] or non-cardiac death), recurrent AMI (re-MI), any revascularization (target lesion revascularization [TLR], target vessel revascularization [TVR], and non-TVR). The secondary endpoint was the incidence of definite or probable stent thrombosis (ST). RESULTS:The 2-year adjusted hazard ratio (HR) of MACE for ZES vs. EES (1.055; 95% confidence interval [CI], 0.843-1.321; p = 0.638), ZES vs. BES (HR, 0.885; 95% CI, 0.626-1.251; p = 0.488), EES vs. BES (HR, 0.889; 95% CI, 0.633-1.250; p = 0.499), and ZES/EES vs. BES (HR, 0.891; 95% CI, 0.648-1.126; p = 0.480) were similar. The occurrence of ST after adjustment were also comparable. In addition, the 2-year adjusted HR for all-cause death, CD, re-MI, TLR, TVR, and non-TVR were not different. CONCLUSIONS:In this study, DP-DES and BP-DES showed comparable safety and efficacy during 2-year follow-up periods. Therefore, DP-DES or BP-DES are equally acceptable in AMI patients with current smoking undergoing PCI.
first_indexed 2024-12-13T23:16:29Z
format Article
id doaj.art-43fe56d112304694a6200276a076667c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T23:16:29Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-43fe56d112304694a6200276a076667c2022-12-21T23:27:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011310e020504610.1371/journal.pone.0205046Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.Yong Hoon KimAe-Young HerMyung Ho JeongByeong-Keuk KimSung-Jin HongDong-Ho ShinJung-Sun KimYoung-Guk KoDonghoon ChoiMyeong-Ki HongYangsoo JangOBJECTIVE:Data concerning the effect of current smoking on solely new-generation drug-eluting stents (DES) are limited. We investigated the impact of current smoking on 2-year clinical outcomes between durable-polymer (DP)-coated DES (zotarolimus-eluting [ZES] and everolimus eluting [EES]) and biodegradable-polymer (BP)-coated biolimus-eluting stent (BES) in acute myocardial infarction (AMI) patients after successful percutaneous coronary intervention (PCI). METHODS:Finally, a total of 8357 AMI patients with current smoking underwent successful PCI with new-generation DES (ZES, EES, and BES) were enrolled and divided into three groups as ZES (n = 3199), EES (n = 3987), and BES group (n = 1171). The primary endpoint was the occurrence of major adverse cardiac events (MACE) defined as all-cause death (cardiac death [CD] or non-cardiac death), recurrent AMI (re-MI), any revascularization (target lesion revascularization [TLR], target vessel revascularization [TVR], and non-TVR). The secondary endpoint was the incidence of definite or probable stent thrombosis (ST). RESULTS:The 2-year adjusted hazard ratio (HR) of MACE for ZES vs. EES (1.055; 95% confidence interval [CI], 0.843-1.321; p = 0.638), ZES vs. BES (HR, 0.885; 95% CI, 0.626-1.251; p = 0.488), EES vs. BES (HR, 0.889; 95% CI, 0.633-1.250; p = 0.499), and ZES/EES vs. BES (HR, 0.891; 95% CI, 0.648-1.126; p = 0.480) were similar. The occurrence of ST after adjustment were also comparable. In addition, the 2-year adjusted HR for all-cause death, CD, re-MI, TLR, TVR, and non-TVR were not different. CONCLUSIONS:In this study, DP-DES and BP-DES showed comparable safety and efficacy during 2-year follow-up periods. Therefore, DP-DES or BP-DES are equally acceptable in AMI patients with current smoking undergoing PCI.http://europepmc.org/articles/PMC6173404?pdf=render
spellingShingle Yong Hoon Kim
Ae-Young Her
Myung Ho Jeong
Byeong-Keuk Kim
Sung-Jin Hong
Dong-Ho Shin
Jung-Sun Kim
Young-Guk Ko
Donghoon Choi
Myeong-Ki Hong
Yangsoo Jang
Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
PLoS ONE
title Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
title_full Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
title_fullStr Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
title_full_unstemmed Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
title_short Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
title_sort impact of current smoking on 2 year clinical outcomes between durable polymer coated stents and biodegradable polymer coated stents in acute myocardial infarction after successful percutaneous coronary intervention data from the kamir
url http://europepmc.org/articles/PMC6173404?pdf=render
work_keys_str_mv AT yonghoonkim impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT aeyoungher impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT myunghojeong impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT byeongkeukkim impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT sungjinhong impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT donghoshin impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT jungsunkim impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT younggukko impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT donghoonchoi impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT myeongkihong impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir
AT yangsoojang impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir